Develops MRI-compatible IV infusion pumps and vital signs monitors for hospitals.
Jun 2026Revenue $86.3M/yrExpenses $58.8M/yr
No trend
Figures by year
Is Iradimed profitable?
Yes. In the 12 months to Jun 2026, revenue was $86.3M and expenses $58.8M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $83.8M | $57.7M | $26.1M |
| Dec 2024 | $73.2M | $51.3M | $22.0M |
| Dec 2023 | $65.6M | $45.5M | $20.0M |
| Dec 2022 | $53.3M | $37.7M | $15.6M |
| Dec 2021 | $41.8M | $32.0M | $9.82M |
| Dec 2020 | $31.7M | $32.5M | −$756K |
| Dec 2019 | $38.5M | $29.9M | $8.65M |
| Dec 2018 | $30.4M | $24.4M | $6.00M |
| Dec 2017 | $23.1M | $21.8M | $1.29M |
| Dec 2016 | $32.5M | $21.6M | $10.9M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.